Granulocyte colony-stimulating factor reduces mortality by suppressing ventricular arrhythmias in acute phase of myocardial infarction in rats

Journal of Cardiovascular Pharmacology

Volumn 52, Issue 4, 2008, Pages 375-380

  Baldo, Marcelo P ^a   Davel, Ana Paula C ^b   Nicoletti Carvalho, José E ^b   Bordin, Silvana ^b   Rossoni, Luciana V ^b   Mill, José G ^a,c  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Avenida Marechal Campos 1468 ^*  (Brazil)

Author keywords

G CSF; Myocardial infarction; Survival; Ventricular arrhythmias

Indexed keywords

CONNEXIN 43; GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTROCARDIOGRAM; HEART BEAT; HEART INFARCTION; HEART INFARCTION SIZE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; ANIMAL; DRUG SCREENING; ELECTROCARDIOGRAPHY; EVALUATION; HEART ARRHYTHMIA; KAPLAN MEIER METHOD; METABOLISM; RANDOMIZATION; SURVIVAL; WISTAR RAT;

ANIMALS; ARRHYTHMIAS, CARDIAC; CONNEXIN 43; DRUG EVALUATION, PRECLINICAL; ELECTROCARDIOGRAPHY; GRANULOCYTE COLONY-STIMULATING FACTOR; KAPLAN-MEIERS ESTIMATE; MALE; MYOCARDIAL INFARCTION; RANDOM ALLOCATION; RATS; RATS, WISTAR; SURVIVAL ANALYSIS;

EID: 58149328807     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31818a2bb0     Document Type: Article

References (41)

1. Zheng ZJ, Croft JB, Giles WH, et al. Sudden cardiac death in the United States, 1989 to 1998. Circulation. 2001;104:2158-2163.
2. Henkel DM, Witt BJ, Gersh BJ, et al. Ventricular arrhythmias after acute myocardial infarction: a 20-year community study. Am Heart J. 2006;151: 806-812.
3. Al-Khatib SM, Stebbins AL, Califf RM, et al. Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial. Am Heart J. 2003;145: 515-521.
4. Maggioni AP, Zuanetti G, Franzosi MG, et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation. 1993;87:312-322.
5. Clark C, Foreman MI, Kane KA, et al. Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size. J Pharm Meth. 1980;3:357-368.
6. Mill JG, Stefanon I, Leite CM, et al. Changes in performance of surviving myocardium after left ventricular infarction in rats. Cardiovasc Res. 1990; 24:748-753.
7. Leenen FHH, Yuan B. Mortality after coronary artery occlusion in different models of cardiac hypertrophy in rats. Hypertension. 2001;37: 209-215.
8. Opitz CF, Mitchell GF, Pfeffer MA, et al. Arrhythmias and death after coronary artery occlusion in the rat. Continuous telemetric ECG monitoring in conscious, untethered rats. Circulation. 1995;92: 253-261.
9. Janse MJ, Kleber AG. Electrophysiological changes and ventricular arrhythmias in the early phase of regional myocardial ischemia. Circ Res. 1981;49:1069-1081.
10. Poelzing S, Rosenbaum DS. Altered connexin43 expression produces arrhythmia substrate in heart failure. Am J Physiol Heart Circ Physiol. 2004;287:1762-1770.
11. Gutstein DE, Danik SB, Lewitton S, et al. Focal gap junction uncoupling and spontaneous ventricular ectopy. Am J Physiol Heart Circ Physiol. 2005;289:H1091-H1098.
12. Lerner DL, Yamada KA, Schuessler RB, et al. Accelerated onset and increased incidence of ventricular arrhythmias induced by ischemia in Cx43-deficient mice. Circulation. 2001;101:547-552.
13. Roell W, Lewalter T, Sasse P, et al. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature. 2007;450:819-824.
14. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood. 1993;11:2844-2853.
15. Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci. 2001;98:10344-10349.
16. Ohtsuka M, Takano H, Zou H, et al. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. FASEB J. 2004;18;851-853.
17. Kuhlmann MT, Kirchhof P, Klocke R, et al. G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased conexin43 expression and arteriogenesis. J Exp Med. 2006;203:87-97.
18. Kuwabara M, Kakinuma Y, Katare RG, et al. Granulocyte colony-stimulating factor activates Wnt signal to sustain gap junction through recruitment of β-catenin and cadherin. FEBS Lett. 2007;581:4821-4830.
19. Walker MJA, Curtis MJ, Hearse DJ, et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res. 1988;22:447-455.
20. Baczkó I, Leprán I, Papp JG. Influence of anesthetics on the incidence of reperfusion induced arrhythmias and sudden death in rats. J Cardiovasc Pharmacol. 2007;29:196-201.
21. Baczkó I, Leprán I, Papp JG. KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats. Eur J Pharmacol. 1997;324:77-83.
22. Deindl E, Zaruba MM, Brunner S, et al. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J. 2006;20:27-36.
23. Siddiqui A, Kowey PR. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies. Curr Opin Cardiol. 2006;21: 517-525.
24. Kolettis TM, Agelaki MG, Baltogiannis GG, et al. Comparative effects of acute vs. chronic oral amiodarone treatment during acute myocardial infarction in rats. Europace. 2007;9:1099-1104.
25. Williams DO, Scherlag BJ, Hope RR, et al. The pathophysiology of malignant ventricular arrhythmias during acute myocardial ischemia. Circulation. 1974;50:1163-1172.
26. Kleber AG, Riegger CB, Janse MJ. Electrical uncoupling and increase of extracellular resistance after induction of ischemia in isolated, arterially perfused rabbit papillary muscle. Circ Res. 1987;61:271-279.
27. Peters NS, Coromilas J, Severs NJ, et al. Disturbed connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation. 1997;95:988-996.
28. Danik SB, Liu F, Zhang J, et al. Modulation of cardiac gap junction expression and arrhythmic susceptibility. Circ Res. 2004;95: 1035-1041.
29. Gutstein DE, Morley GE, Tamaddon H, et al. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res. 2001;88:333-339.
30. Kaplinsky E, Ogawa S, Balke W, et al. Two periods of early ventricular arrhythmia in the canine acute myocardial infarction model. Circulation. 1979;60:397-403.
31. Smith WT, Fleet WF, Johnson TA, et al. The 1b phase of ventricular arrhythmias in ischemic in situ porcine heart is related to changes in cell-to-cell electrical coupling. Circulation. 1995;92:3051-3060.
32. Curtis MJ. Characterisation, utilization and clinical relevance of isolated perfused heart models of ischaemia-induced ventricular fibrillation. Cardiovasc Res. 1998;39:194-215.
33. Clements-Jewery H, Hearse DJ, Curtis MJ. Neutrophil ablation with anti-serum does not protect against phase 2 ventricular arrhythmias in anaesthetized rats with myocardial infarction. Cardiovasc Res. 2007;73: 761-769.
34. Clements-Jewery H, Hearse DJ, Curtis MJ. Independent contribution of catecholamines to arrhythmogenesis during evolving infarction in the isolated rat heart. Br J Pharmacol. 2002;135:807-815.
35. Li J, Patel VV, Kostetskii I, et al. Cardiac-specific loss of N-cadherin leads to alteration in connexins with conduction slowing and arrhythmogenesis. Circ Res. 2005;97:474-481.
36. Li Y, Fukuda N, Yokoyama SI, et al. Effects of G-CSFon cardiac remodeling and arterial hyperplasia in rats. Eur J Pharmacol. 2006;549:98-106.
37. Werneck-de-Castro JP, Costa-e-Sousa RH, de Oliveira PF, et al. G-CSF does not improve systolic function in a rat model of acute myocardial infarction. Basic Res Cardiol. 2006;101:494-501.
38. Deten A, Volz HC, Clamors S, et al. Hematopoietic stem cells do not repair the infracted mouse heart. Cardiovasc Res. 2005;65:52-63.
39. Harada M, Qin Y, Takano H, et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med. 2005;11:305-311.
40. Takahama H, Minamino T, Hirata A, et al. Granulocyte colony-stimulating factor mediates cardioprotection against ischemia/reperfusion injury via phosphatidylinositol-3-kinase/Akt pathway in canine hearts. Cardiovasc Drugs Ther. 2006;20:159-165.
41. Ueda K, Takano H, Hasegawa H, et al. Granulocyte colony stimulating factor directly inhibits myocardial ischemia-reperfusion injury through Akt-endothelial NO syntase pathway. Arterioscler Thromb Vasc Biol. 2006;26:e108-e113.